Skip to content

CUE · Cue Biopharma, Inc.

Healthcare · −10.5% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 6 feeds behind: Insider filings, 2 days, and 5 more · Every feed →

On this page

The market view

Price chart

The interactive CUE chart (by TradingView) loads here.

Our take

2 rules fired on CUE

In short: none of these rules has solid or some evidence yet, so they show no clear lean on CUE.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for CUE, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on CUE, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of CUE. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 21, 2026–Oct 18, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
3
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–3
Oct 20, 2025Oct 18, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Aug 14, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 1. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 20260Partial; excluded
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period0Within stored history
Insider sales · Short history

Only 1 earlier period is on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 20263Partial; excluded
Aug 24, 2026–Sep 20, 20260Within stored history
Sep 21, 2026–Oct 18, 2026Latest period3Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 2026—Unavailable
Aug 24, 2026–Sep 20, 2026—Unavailable
Sep 21, 2026–Oct 18, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 20, 2025–Nov 16, 2025—Unavailable
Nov 17, 2025–Dec 14, 2025—Unavailable
Dec 15, 2025–Jan 11, 2026—Unavailable
Jan 12, 2026–Feb 8, 2026—Unavailable
Feb 9, 2026–Mar 8, 2026—Unavailable
Mar 9, 2026–Apr 5, 2026—Unavailable
Apr 6, 2026–May 3, 2026—Unavailable
May 4, 2026–May 31, 2026—Unavailable
Jun 1, 2026–Jun 28, 2026—Unavailable
Jun 29, 2026–Jul 26, 2026—Unavailable
Jul 27, 2026–Aug 23, 2026—Unavailable
Aug 24, 2026–Sep 20, 2026—Unavailable
Sep 21, 2026–Oct 18, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Owners & lobbying

Insiders · Oct 2026

  1. Disclosed
    Michael Vincent Meluzio · Sale

    Transaction dated Oct 12, 2026

  2. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Oct 12, 2026

  3. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Oct 12, 2026

  4. Disclosed
    Sumita Ray · Sale

    Transaction dated Oct 12, 2026

  5. Filed
  6. Filed
All 28 records in this snapshot
  1. Disclosed
    Michael Vincent Meluzio · Sale

    Transaction dated Oct 12, 2026

  2. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Oct 12, 2026

  3. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Oct 12, 2026

  4. Disclosed
    Sumita Ray · Sale

    Transaction dated Oct 12, 2026

  5. Filed
  6. Filed
  7. Record date
  8. Filed
  9. Filed
  10. Filed
  11. Filed
  12. Disclosed
    Michael Vincent Meluzio · Sale

    Transaction dated Aug 13, 2026

  13. Disclosed
    Michael Vincent Meluzio · Sale

    Transaction dated Aug 13, 2026

  14. Disclosed
    Michael Vincent Meluzio · Sale

    Transaction dated Aug 13, 2026

  15. Disclosed
    Sumita Ray · Sale

    Transaction dated Aug 13, 2026

  16. Disclosed
    Sumita Ray · Sale

    Transaction dated Aug 13, 2026

  17. Disclosed
    Sumita Ray · Sale

    Transaction dated Aug 13, 2026

  18. Filed
  19. Filed
  20. Filed
  21. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Aug 13, 2026

  22. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Aug 12, 2026

  23. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Aug 13, 2026

  24. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Aug 13, 2026

  25. Disclosed
    Shao-Lee Lin · Sale

    Transaction dated Aug 12, 2026

  26. Filed
  27. Filed
  28. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on CUE disclosed in the last 90 days.

See every Congress trade on CUE →

Company insiders

0 buys · 6 sells (15 filed lots) · $2.4M sold

  1. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$275Kdisclosed Oct 14 · filed 2 days after the trade
  2. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$51.7Kdisclosed Oct 14 · filed 2 days after the trade
  3. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$30.5Kdisclosed Oct 14 · filed 2 days after the trade
  4. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$32.1Kdisclosed Oct 14 · filed 2 days after the trade
  5. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$125disclosed Aug 17 · filed 4 days after the trade
  6. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$93disclosed Aug 17 · filed 4 days after the trade
  7. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$196Kdisclosed Aug 17 · filed 4 days after the trade
  8. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$70Kdisclosed Aug 17 · filed 4 days after the trade
  9. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$44.6Kdisclosed Aug 17 · filed 4 days after the trade
  10. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$125Kdisclosed Aug 17 · filed 4 days after the trade
See every insider trade on CUE →

Big holders (Schedule 13D / 13G): 2 filings in the last 90 days · newest: Lin Shao-Lee (13D), Aug 21, 2026 ↗

Filings & events

Company filings (8-K) 53

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Directors or officers joined, left or got new pay · item 5.0212
  • Other events · item 8.018
  • Quarterly or yearly results · item 2.025
  • Signed a major agreement · item 1.015
  • Shareholder vote results · item 5.074
  • Shared information with investors · item 7.013

Filing red flags 28

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Planned insider sales (Form 144) 5

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

4 in the last 90 days · 5 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 2

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 1 filing
  • 13G, just holds: 1 filing

Filed by Lin Shao-Lee · Driehaus Capital Management LLC

Biggest named funds (13F)

The largest CUE holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on CUE

  1. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$275Kdisclosed Oct 14 · filed 2 days after the trade
  2. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$51.7Kdisclosed Oct 14 · filed 2 days after the trade
  3. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$30.5Kdisclosed Oct 14 · filed 2 days after the trade
  4. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$32.1Kdisclosed Oct 14 · filed 2 days after the trade
  5. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$125disclosed Aug 17 · filed 4 days after the trade
  6. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$93disclosed Aug 17 · filed 4 days after the trade
  7. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$196Kdisclosed Aug 17 · filed 4 days after the trade
  8. ▼ SELLSumita Ray Chief Legal Compliance OfficerCUE Cue Biopharma, Inc.$70Kdisclosed Aug 17 · filed 4 days after the trade
  9. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$44.6Kdisclosed Aug 17 · filed 4 days after the trade
  10. ▼ SELLMichael Vincent Meluzio VP, Prin. Accounting OfficerCUE Cue Biopharma, Inc.$125Kdisclosed Aug 17 · filed 4 days after the trade
  11. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$66.8Kdisclosed Aug 14 · filed 1 day after the trade
  12. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$160Kdisclosed Aug 14 · filed 2 days after the trade
  13. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$147Kdisclosed Aug 14 · filed 1 day after the trade
  14. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$308Kdisclosed Aug 14 · filed 1 day after the trade
  15. ▼ SELLShao-Lee Lin Chief Executive OfficerCUE Cue Biopharma, Inc.$924Kdisclosed Aug 14 · filed 2 days after the trade
See the trades on CUE in the feed →
People & votes

Which members of Congress traded CUE, sponsored bills that touch it and voted on them — opens here.